LeonaBio (LONA) Free Cash Flow (2019 - 2026)

LeonaBio (LONA) has 8 years of Free Cash Flow data on file, last reported at -$20.9 million in Q1 2026.

• On a quarterly basis, Free Cash Flow fell 42.54% year-over-year to -$20.9 million in Q1 2026; TTM through Mar 2026 was -$52.0 million, a 39.61% increase from a year earlier, with the FY2025 full-year figure at -$45.7 million, up 52.96% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$20.9 million, down from -$19.4 million in the prior quarter.
• Over the last five years, Free Cash Flow for LONA reached as high as -$4.7 million in Q3 2025 and fell as low as -$26.4 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$19.9 million across 5 years, with a median of -$21.9 million in 2022.
• Across the five-year window, Free Cash Flow sank 144.09% in 2022 and jumped 79.72% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$15.7 million in 2022, then sank by 67.81% to -$26.3 million in 2023, then advanced by 1.06% to -$26.0 million in 2024, then climbed by 25.43% to -$19.4 million in 2025, then declined by 7.76% to -$20.9 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$20.9 million in Q1 2026, -$19.4 million in Q4 2025, and -$4.7 million in Q3 2025.